ICH E18: Genomic Sampling Methodologies for Future Use

Navigant featured in BioStorage Technologies

Many regulatory agencies including the FDA, EMA and PMDA have laid out guidelines encouraging genomic sample collection during drug product development. In doing so there is a greater chance of properly evaluating the drug’s effectiveness. Suzanne O’Shea discusses the guidelines and provides recommendations for the future of genomic sampling.


Back to top